Atlas Trials

Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan

Clinical trial NCT01051960 · COMPLETED

Trial details

NCT number
NCT01051960
Sponsor
University of California, Los Angeles
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Systemic SclerosisShortness of BreathPulmonary Hypertension
Start date
2009-03-01
Primary completion
2010-06-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.